Christopher Bamba News Today

Philippine Canadian Inquirer PH, US ink deals on energy, health, Internet satellites, climate tech

Photo courtesy of NTF Against Covid-19 MANILA - Local pharmaceutical firm Lloyd Laboratories Inc. (LLI) is eyeing a "fill and finish" operation for a new Chinese vaccine against coronavirus disease (Covid-19) that is still undergoing clinical trials. In a virtual media interview Thursday, LLI medical consultant Dr. Antonio Ligsay said the company has partnered with Livzon Biotech's Livzon Mabpharm, Inc. for the phase three clinical trial of the V-01, a code name for the recombinant...

Molnupiravir(Antara) MANILA - As Philippine pharmaceutical firm Lloyd Laboratories Inc. (LLI) aims producing molnupiravir in the country, prices of this coronavirus disease 2019 (Covid-19) drug could go down by 30 to 50 percent. LLI Business Development director Christopher Bamba said retail prices of imported molnupiravir cost around PHP100 to PHP150 per 200-milligram capsule. "For our pricing, we are usually 30 to 50 percent lower and this is our price strategy being a local manufacturer ...

Lloyd Laboratories Inc., a firm eyeing to start its production of Molnupiravir this month, is also aiming to apply for an emergency use authorization (EUA) by February for a Covid-19 vaccine that is currently under clinical trials. Antonio Ligsay, medical consultant of the company, told the reporters on Thursday that…